<?xml version='1.0'?><!DOCTYPE Annotation PUBLIC "//GENIA//DTD GENIA ANNOTATION EVENT 2.0//EN_Modified" "../ModifiedGENIAtypes/Modified_GENIA_event_20.dtd"><Annotation annotates="http://www.ncbi.nlm.nih.gov/entrez/eutils/efetch.fcgi?db=pubmed&amp;retmode=xml&amp;rettype=medline&amp;id=7964616" created="26/10/2006" creator="Yo Shidahara"><PubmedArticleSet><PubmedArticle><MedlineCitation>
<PMID>7964616</PMID>
<Article>
<ArticleTitle>
<sentence id="S1"><term id="A1" sem="DNA_domain_or_region">DNA</term>-binding studies of the <term id="T1" lex="Epstein-Barr_virus_nuclear_antigen_2" sem="Protein_molecule"><term id="T2" lex="epstein-Barr_virus" sem="Virus">Epstein-Barr virus</term> nuclear antigen 2</term> (<term id="T3" lex="EBNA-2" sem="Protein_molecule">EBNA-2</term>): evidence for complex formation by <term id="T4" lex="latent_membrane_protein_gene_promoter-binding_protein" sem="Protein_family_or_group">latent membrane protein gene promoter-binding proteins</term> in <term id="T5" lex="EBNA-2-positive_cell_line" sem="Cell_cultured"><term id="T6" lex="EBNA-2" sem="Protein_molecule">EBNA-2</term>-positive cell lines</term>.</sentence>
<event KT="Investigation" id="E1" uncertainty="doubtful">
<type class="Binding"/>
<theme idref="A1"/>
<theme idref="T1"/>
<clue>DNA-<clueType>binding studies</clueType> <linkTheme>of</linkTheme> the Epstein-Barr virus nuclear antigen 2 (EBNA-2): evidence for complex formation by latent membrane protein gene promoter-binding proteins in EBNA-2-positive cell lines.</clue>
</event>
<event CL="L2" KT="Analysis" id="E2">
<type class="Binding"/>
<theme idref="T4"/>
<clue>DNA-binding studies of the Epstein-Barr virus nuclear antigen 2 (EBNA-2): <clueKT><clueCL>evidence</clueCL></clueKT> for <clueType>complex formation</clueType> <linkTheme>by</linkTheme> latent membrane protein gene promoter-binding proteins <clueLoc>in EBNA-2-positive cell lines</clueLoc>.</clue>
</event>
</ArticleTitle>
<Abstract>
<AbstractText>
<sentence id="S2">The <term id="T7" lex="Epstein-Barr_virus_(EBV)_nuclear_antigen_2" sem="Protein_molecule"><term id="T8" lex="epstein-Barr_virus" sem="Virus">Epstein-Barr virus</term> (<term id="T9" lex="EBV" sem="Virus">EBV</term>) nuclear antigen 2</term> (<term id="T10" lex="EBNA-2" sem="Protein_molecule">EBNA-2</term>) protein is essential for the immortalization of <term id="T11" lex="human_primary_B_cell" sem="Cell_natural">human primary B cells</term> by <term id="T12" lex="EBV" sem="Virus">EBV</term>.</sentence>
<event KT="Other" id="E3">
<type class="Cellular_physiological_process"/>
<theme idref="T11"/>
<clue>The Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA-2) protein is essential for the <clueType>immortalization</clueType> <linkTheme>of</linkTheme> human primary B cells by EBV.</clue>
</event>
<event KT="Other" id="E103">
<type class="Positive_regulation"/>
<theme idref="E3"/>
<cause idref="T12"/>
<clue>The Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA-2) protein is essential for the <clueType>immortalization</clueType> of human primary B cells <linkCause>by</linkCause> EBV.</clue>
</event>
<event KT="Fact" id="E5">
<type class="Positive_regulation"/>
<theme idref="E3"/>
<cause idref="T10"/>
<clue>The Epstein-Barr virus (EBV) nuclear antigen 2 (EBNA-2) protein is <clueType>essential</clueType> <linkTheme>for</linkTheme> the immortalization of human primary B cells by EBV.</clue>
</event>
<sentence id="S3"><term id="T13" lex="EBNA-2" sem="Protein_molecule">EBNA-2</term> trans-activates <cons id="T14" lex="(AND cellular_gene viral_gene)" sem="(AND DNA_family_or_group DNA_family_or_group)"><frag id="F1"><term id="A2" sem="DNA_domain_or_region">cellular</term></frag> and <frag id="F2"><term id="A3" sem="DNA_domain_or_region">viral</term></frag> <frag id="F3"><term id="A4" sem="DNA_domain_or_region">genes</term></frag></cons> like <term id="T15" lex="CD23" sem="DNA_domain_or_region">CD23</term>, <term id="T16" lex="c-fgr" sem="DNA_domain_or_region">c-fgr</term>, <term id="T17" lex="latent_membrane_protein_1" sem="Protein_molecule">latent membrane protein 1</term> (<term id="T18" lex="LMP1" sem="Protein_molecule">LMP1</term>) and <term id="T19" lex="terminal_protein_1" sem="Protein_molecule">terminal protein 1</term> (<term id="T20" lex="TP1" sem="Protein_molecule">TP1</term>).</sentence>
<event KT="Fact" id="E106">
<type class="Positive_regulation"/>
<theme idref="A2" idref1="A4"/>
<cause idref="T13"/>
<clue>EBNA-2 <clueType>trans-activates</clueType> cellular and viral genes like CD23, c-fgr, latent membrane protein 1 (LMP1) and terminal protein 1 (TP1).</clue>
</event>
<event KT="Fact" id="E6">
<type class="Positive_regulation"/>
<theme idref="A3" idref1="A4"/>
<cause idref="T13"/>
<clue>EBNA-2 <clueType>trans-activates</clueType> cellular and viral genes like CD23, c-fgr, latent membrane protein 1 (LMP1) and terminal protein 1 (TP1).</clue>
</event>
<event KT="Fact" id="E7">
<type class="Positive_regulation"/>
<theme idref="T15"/>
<cause idref="T13"/>
<clue>EBNA-2 <clueType>trans-activates</clueType> <corefTheme idref1="T15">cellular</corefTheme> and viral <corefTheme idref1="T15">genes</corefTheme> like CD23, c-fgr, latent membrane protein 1 (LMP1) and terminal protein 1 (TP1).</clue>
</event>
<event KT="Fact" id="E8">
<type class="Positive_regulation"/>
<theme idref="T16"/>
<cause idref="T13"/>
<clue>EBNA-2 <clueType>trans-activates</clueType> <corefTheme idref1="T16">cellular</corefTheme> and viral <corefTheme idref1="T16">genes</corefTheme> like CD23, c-fgr, latent membrane protein 1 (LMP1) and terminal protein 1 (TP1).</clue>
</event>
<event KT="Fact" id="E9">
<type class="Positive_regulation"/>
<theme idref="T18"/>
<cause idref="T13"/>
<clue>EBNA-2 <clueType>trans-activates</clueType> cellular and <corefTheme>viral genes</corefTheme> like CD23, c-fgr, latent membrane protein 1 (LMP1) and terminal protein 1 (TP1).</clue>
</event>
<event KT="Fact" id="E10">
<type class="Positive_regulation"/>
<theme idref="T20"/>
<cause idref="T13"/>
<clue>EBNA-2 <clueType>trans-activates</clueType> cellular and <corefTheme>viral genes</corefTheme> like CD23, c-fgr, latent membrane protein 1 (LMP1) and terminal protein 1 (TP1).</clue>
</event>
<sentence id="S4">Trans-activation of the <term id="T21" lex="TP1_promoter" sem="DNA_domain_or_region">TP1 promoter</term> and of the <term id="T22" lex="BamHI_C_promoter" sem="DNA_domain_or_region">BamHI C promoter</term> has already been investigated in detail and appears to be mediated via <term id="T23" lex="protein-protein_interaction" sem="Other">protein-protein interactions</term> and not by direct binding of <term id="T24" lex="EBNA-2_type_A" sem="Protein_molecule"><term id="T25" lex="EBNA-2" sem="Protein_molecule">EBNA-2</term> type A</term> (of <term id="T26" lex="EBV_type_1" sem="Virus">EBV type 1</term>) to the <term id="A5" sem="DNA_domain_or_region">DNA</term>.</sentence>
<event KT="Investigation" Source="Other" id="E11">
<type class="Positive_regulation"/>
<theme idref="T21"/>
<clue><clueType>Trans-activation</clueType> <linkTheme>of</linkTheme> the TP1 promoter and of the BamHI C promoter <clueSource>has already been</clueSource> <clueKT>investigated</clueKT> in detail and appears to be mediated via protein-protein interactions and not by direct binding of EBNA-2 type A (of EBV type 1) to the DNA.</clue>
</event>
<event KT="Investigation" Source="Other" id="E12">
<type class="Positive_regulation"/>
<theme idref="T22"/>
<clue><clueType>Trans-activation</clueType> of the TP1 promoter and <linkTheme>of</linkTheme> the BamHI C promoter <clueSource>has already been</clueSource> <clueKT>investigated</clueKT> in detail and appears to be mediated via protein-protein interactions and not by direct binding of EBNA-2 type A (of EBV type 1) to the DNA.</clue>
</event>
<event CL="L2" KT="Analysis" id="E13" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E11"/>
<cause idref="T23"/>
<clue>Trans-activation of the TP1 promoter and of the BamHI C promoter has already been investigated in detail and <clueKT><clueCL>appears</clueCL></clueKT> to be <clueType>mediated</clueType> <linkCause>via</linkCause> protein-protein interactions and not by direct binding of EBNA-2 type A (of EBV type 1) to the DNA.</clue>
</event>
<event CL="L2" KT="Analysis" id="E14" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E12"/>
<cause idref="T23"/>
<clue>Trans-activation of the TP1 promoter and of the BamHI C promoter has already been investigated in detail and <clueKT><clueCL>appears</clueCL></clueKT> to be <clueType>mediated</clueType> <linkCause>via</linkCause> protein-protein interactions and not by direct binding of EBNA-2 type A (of EBV type 1) to the DNA.</clue>
</event>
<event KT="Other" id="E15">
<type class="Binding"/>
<theme idref="T24"/>
<theme idref="A5"/>
<clue>Trans-activation of the TP1 promoter and of the BamHI C promoter has already been investigated in detail and appears to be mediated via protein-protein interactions and not by direct <clueType>binding</clueType> <linkTheme>of</linkTheme> EBNA-2 type A (of EBV type 1) <linkTheme>to</linkTheme> the DNA.</clue>
</event>
<event CL="L2" KT="Analysis" Polarity="Negative" assertion="non-exist" id="E16" uncertainty="probable">
<type class="Positive_regulation"/>
<theme idref="E12"/>
<cause idref="E15"/>
<clue>Trans-activation of the TP1 promoter and of the BamHI C promoter has already been investigated in detail and <clueKT><clueCL>appears</clueCL></clueKT> to be <clueType>mediated</clueType> via protein-protein interactions and <cluePolarity>not</cluePolarity> <linkCause>by</linkCause> direct binding of EBNA-2 type A (of EBV type 1) to the DNA.</clue>
</event>
<sentence id="S5"><term id="T27" lex="EBNA-2" sem="Protein_molecule">EBNA-2</term> is able to trans-activate the expression of the <term id="T28" lex="LMP_gene" sem="DNA_domain_or_region">LMP gene</term> in several cell lines.</sentence>
<event KT="Other" id="E17">
<type class="Gene_expression"/>
<theme idref="T28"/>
<clue>EBNA-2 is able to trans-activate the <clueType>expression</clueType> <linkTheme>of</linkTheme> the LMP gene <clueLoc>in several cell lines</clueLoc>.</clue>
</event>
<event CL="L2" KT="Analysis" id="E18">
<type class="Positive_regulation"/>
<theme idref="E17"/>
<cause idref="T27"/>
<clue>EBNA-2 is <clueKT><clueCL>able</clueCL></clueKT> to <clueType>trans-activate</clueType> the expression of the LMP gene in several cell lines.</clue>
</event>
<sentence id="S6">Various reports have delineated the <term id="A6" sem="DNA_domain_or_region"><term id="T29" lex="cis-acting_element" sem="DNA_domain_or_region">cis-acting elements</term> of the <term id="T30" lex="LMP_promoter" sem="DNA_domain_or_region">LMP promoter</term></term> through which <term id="T31" lex="EBNA-2" sem="Protein_molecule">EBNA-2</term> mediates <term id="T32" lex="trans-activation" sem="Other">trans-activation</term>.</sentence>
<event KT="Other" id="E19">
<type class="Positive_regulation"/>
<theme idref="A6"/>
<cause idref="T31"/>
<clue>Various reports have delineated the cis-acting elements of the LMP promoter <linkTheme>through which</linkTheme> EBNA-2 <clueType>mediates</clueType> trans-activation.</clue>
<comment>TPS A6</comment></event>
<event KT="Fact" id="E20">
<type class="Positive_regulation"/>
<theme idref="T32"/>
<cause idref="E19"/>
<clue>Various reports have delineated the cis-acting elements of the LMP promoter <linkCause>through which</linkCause> EBNA-2 <clueType>mediates</clueType> trans-activation.</clue>
</event>
<sentence id="S7">To determine whether <term id="T33" lex="EBNA-2" sem="Protein_molecule">EBNA-2</term> also trans-activates the <term id="T34" lex="LMP_promoter" sem="DNA_domain_or_region">LMP promoter</term> by <term id="T35" lex="protein-protein_interaction" sem="Other">protein-<term id="A103" sem="Protein_family_or_group">protein</term> interactions</term>, we performed a series of <term id="T36" lex="gel_retardation_assay" sem="Other">gel retardation assays</term> and competition experiments with <term id="T37" lex="LMP_promoter_fragment" sem="DNA_molecule"><term id="T38" lex="LMP_promoter" sem="DNA_domain_or_region">LMP promoter</term> fragments</term> of different sizes.</sentence>
<event KT="Other" id="E21">
<type class="Binding"/>
<theme idref="T33"/>
<theme idref="A103"/>
<clue>To determine whether EBNA-2 also trans-activates the LMP promoter by <corefTheme>protein</corefTheme>-protein <clueType>interactions</clueType>, we performed a series of gel retardation assays and competition experiments with LMP promoter fragments of different sizes.</clue>
</event>
<event KT="Investigation" id="E22" uncertainty="doubtful">
<type class="Positive_regulation"/>
<theme idref="T34"/>
<cause idref="E21"/>
<clue><clueKT>To determine</clueKT> whether EBNA-2 also <clueType>trans-activates</clueType> the LMP promoter <linkCause>by</linkCause> protein-protein interactions, we performed a series of gel retardation assays and competition experiments with LMP promoter fragments of different sizes.</clue>
<comment>CAUTION: E21=EBNA-2-protein complex</comment></event>
<sentence id="S8">We determined that the <term id="T39" lex="protein-binding_region" sem="DNA_domain_or_region"><term id="A7" sem="Protein_family_or_group">protein</term>-binding region</term> on the <term id="T40" lex="LMP_promoter" sem="DNA_domain_or_region">LMP promoter</term> was within a <term id="T41" lex="42_bp_fragment" sem="DNA_domain_or_region">42 bp fragment</term> encompassing <term id="T42" lex="nucleotides_-135_to_-176" sem="DNA_substructure">nucleotides -135 to -176</term> relative to the <term id="T43" lex="LMP_transcriptional_start_site" sem="DNA_domain_or_region">LMP transcriptional start site</term>.</sentence>
<event KT="Analysis" id="E23">
<type class="Binding"/>
<theme idref="T40"/>
<theme idref="A7"/>
<clue>We <clueKT>determined</clueKT> that the protein-<clueType>binding</clueType> region <linkTheme>on</linkTheme> the LMP promoter was within a 42 bp fragment encompassing nucleotides -135 to -176 relative to the LMP transcriptional start site.</clue>
</event>
<sentence id="S9">None of the <term id="A102" sem="DNA_family_or_group">DNA fragments investigated</term> indicated interaction of <term id="T44" lex="EBNA-2" sem="Protein_molecule">EBNA-2</term> with the <term id="A8" sem="DNA_domain_or_region">DNA</term> via <term id="T45" lex="protein-protein_interaction" sem="Other">protein-<term id="A101" sem="Protein_family_or_group">protein</term> interactions</term>.</sentence>
<event KT="Other" id="E124">
<type class="Binding"/>
<theme idref="T44"/>
<theme idref="A101"/>
<clue>None of the DNA fragments investigated indicated interaction of EBNA-2 with the DNA via <corefTheme>protein</corefTheme>-protein <clueType>interactions</clueType>.</clue>
<comment>TPS A102</comment></event>
<event CL="L2" KT="Analysis" Polarity="Negative" assertion="non-exist" id="E224">
<type class="Positive_regulation"/>
<theme idref="E24"/>
<cause idref="E124"/>
<clue><cluePolarity>None</cluePolarity> of the DNA fragments investigated <clueKT><clueCL>indicated</clueCL></clueKT> interaction of EBNA-2 with the DNA <linkTheme>via</linkTheme> protein-protein interactions.</clue>
<comment>NO CLUETYPE</comment></event>
<event KT="Other" id="E24">
<type class="Binding"/>
<theme idref="T44"/>
<theme idref="A102"/>
<clue>None of the DNA fragments investigated indicated <clueType>interaction</clueType> <linkTheme>of</linkTheme> EBNA-2 <linkTheme>with</linkTheme> <corefTheme>the DNA</corefTheme> via protein-protein interactions.</clue>
</event>
<sentence id="S10">No significant differences between <term id="T46" lex="EBNA-2" sem="Protein_molecule">EBNA-2</term>-positive and <term id="T47" lex="EBNA-2" sem="Protein_molecule">EBNA-2</term>-negative <term id="T48" lex="nuclear_extract" sem="Cell_component">nuclear extracts</term> could be seen in the <term id="T49" lex="gel_retardation_assay" sem="Other">gel retardation assay</term> under conditions that clearly showed binding of <term id="T50" lex="EBNA-2A" sem="Protein_molecule">EBNA-2A</term> to the <term id="T51" lex="TP1_promoter" sem="DNA_domain_or_region">TP1 promoter</term>.</sentence>
<event KT="Analysis" id="E26">
<type class="Binding"/>
<theme idref="T50"/>
<theme idref="T51"/>
<clue>No significant differences between <clueLoc>EBNA-2-positive</clueLoc> and EBNA-2-negative <clueLoc>nuclear extracts</clueLoc> could be seen <clueExperiment>in the gel retardation assay under conditions</clueExperiment> that clearly <clueKT>showed</clueKT> <clueType>binding</clueType> <linkTheme>of</linkTheme> EBNA-2A <linkTheme>to</linkTheme> the TP1 promoter.</clue>
</event>
<event KT="Analysis" id="E126">
<type class="Binding"/>
<theme idref="T50"/>
<theme idref="T51"/>
<clue>No significant differences between EBNA-2-positive and <clueLoc>EBNA-2-negative nuclear extracts</clueLoc> could be seen <clueExperiment>in the gel retardation assay under conditions</clueExperiment> that clearly <clueKT>showed</clueKT> <clueType>binding</clueType> <linkTheme>of</linkTheme> EBNA-2A <linkTheme>to</linkTheme> the TP1 promoter.</clue>
</event>
<sentence id="S11">However, analysis of <term id="T52" lex="sucrose_gradient_fraction" sem="Other">sucrose gradient fractions</term> in the <term id="T53" lex="gel_retardation_assay" sem="Other">gel retardation assay</term> provided evidence that the <term id="T54" lex="LMP_promoter-binding_protein" sem="Protein_family_or_group"><term id="T55" lex="LMP_promoter" sem="DNA_domain_or_region">LMP promoter</term>-binding <term id="A9" sem="Protein_family_or_group">proteins</term></term> form a complex of higher M(r) in <term id="T56" lex="EBNA-2-positive_cell_extract" sem="Other"><term id="T57" lex="EBNA-2-positive_cell" sem="Cell_natural"><term id="T58" lex="EBNA-2" sem="Protein_molecule">EBNA-2</term>-positive cell</term> extracts</term>.</sentence>
<event CL="L2" KT="Analysis" id="E27">
<type class="Binding"/>
<theme idref="T54"/>
<clue>However, <clueExperiment>analysis of sucrose gradient fractions in the gel retardation assay</clueExperiment> provided <clueKT><clueCL>evidence</clueCL></clueKT> that the LMP promoter-binding proteins <clueType>form a complex</clueType> of higher M(r) <clueLoc>in EBNA-2-positive cell extracts</clueLoc>.</clue>
</event>
<event KT="Other" id="E28">
<type class="Binding"/>
<theme idref="T55"/>
<theme idref="A9"/>
<clue>However, analysis of sucrose gradient fractions in the gel retardation assay provided evidence that the LMP promoter-<clueType>binding</clueType> proteins form a complex of higher M(r) in EBNA-2-positive cell extracts.</clue>
</event>
<sentence id="S12">These complexes were destroyed by <term id="A10" sem="Inorganic_compound">detergent</term>.</sentence>
<event id="E29">
<type/>
<theme idref="E27"/>
<cause idref="A10"/>
<clue><corefTheme>These complexes</corefTheme> were <clueType>destroyed</clueType> <linkCause>by</linkCause> detergent.</clue>
<comment>SOO</comment></event>
<sentence id="S13">We deduce from these results that <term id="T59" lex="EBNA-2-positive_cell" sem="Cell_cultured"><term id="T60" lex="EBNA-2" sem="Protein_molecule">EBNA-2</term>-positive cells</term> might indeed contain <term id="T61" lex="specific_complex" sem="Protein_complex">specific complexes</term> bound to the <term id="T62" lex="LMP_promoter" sem="DNA_domain_or_region">LMP promoter</term> which are, however, too labile to be detected in a standard <term id="T63" lex="gel_retardation_assay" sem="Other">gel retardation assay</term>.</sentence>
<event CL="L1" KT="Analysis" id="E30" uncertainty="probable">
<type class="Binding"/>
<theme idref="T61"/>
<theme idref="T62"/>
<clue>We <clueKT>deduce</clueKT> from these results that <clueLoc>EBNA-2-positive cells</clueLoc> <clueCL>might</clueCL> indeed contain specific complexes <clueType>bound</clueType> <linkTheme>to</linkTheme> the LMP promoter which are, however, too labile to be detected in a standard gel retardation assay.</clue>
</event>
</AbstractText>
</Abstract></Article></MedlineCitation></PubmedArticle></PubmedArticleSet></Annotation>
